Drugs / Umbilical Cord Blood-Derived Stem Cells and Exosomes
Umbilical Cord Blood-Derived Stem Cells and Exosomes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07587047 | Jun 2026 → Jan 2028 expected | chronic pain syndrome | Adia Med of Winter Park LLC | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Blood-Derived Stem Cells and Exosomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07587047 ↗ |
| Modality | Cell therapy | “cryopreserved allogeneic umbilical cord blood-derived product containing viable mononuclear cells (including hematopoietic and mesenchymal stem/stromal cells) and exosomes” NCT07587047 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT07587047 ↗ |